Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- Study of LY3039478 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of LY3039478 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02906618).
- Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring: Complete Statistical AnalysisIndependent statistical analysis of Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring: primary endpoint results, effect estimate…
- Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Metoclopramide in Small Bowel Capsule Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Study of Metoclopramide in Small Bowel Capsule Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01630109).
- Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting: Complete Statistical AnalysisIndependent statistical analysis of Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C): Complete Statistical AnalysisIndependent statistical analysis of Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of MLN8237 in Participants With Advanced Hematological Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of MLN8237 in Participants With Advanced Hematological Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00697346).
- Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212): Complete Statistical AnalysisIndependent statistical analysis of Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis: Complete Statistical AnalysisIndependent statistical analysis of Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Nasal Insulin to Fight Forgetfulness – Device Study: Complete Statistical AnalysisIndependent statistical analysis of Study of Nasal Insulin to Fight Forgetfulness - Device Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03857321).
- Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139): Complete Statistical AnalysisIndependent statistical analysis of Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate…
- Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of NKTR 255 in Combination With Cetuximab in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of NKTR 255 in Combination With Cetuximab in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma: Complete Statistical AnalysisIndependent statistical analysis of Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of OMNI Surgical System and iStent for Eyes With OAG (Trident): Complete Statistical AnalysisIndependent statistical analysis of Study of OMNI Surgical System and iStent for Eyes With OAG (Trident): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of PEG-Intron for Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Study of PEG-Intron for Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00396019).
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355): primary endpoint results, effect estimate…
- Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): primary endpoint results, effect estimate…
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): primary endpoint results, effect estimate…
- Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02998268).
- Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been…
- Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies: Complete Statistical AnalysisIndependent statistical analysis of Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies: primary endpoint results, effect estimate with confidence…
- STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: Complete Statistical AnalysisIndependent statistical analysis of STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Prasugrel in Korean Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study of Prasugrel in Korean Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01591317).
- Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: Complete Statistical AnalysisIndependent statistical analysis of Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: Complete Statistical AnalysisIndependent statistical analysis of Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: primary…
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Quadrivalent Influenza Vaccine Among Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Quadrivalent Influenza Vaccine Among Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240746).
- Study of Ramucirumab in Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Ramucirumab in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721162).
- Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): Complete Statistical AnalysisIndependent statistical analysis of Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Repeat Intranodal Injection of Memgen’s Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Complete Statistical AnalysisIndependent statistical analysis of Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: Complete Statistical AnalysisIndependent statistical analysis of Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02052882).
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04785612).
- Study of Ruxolitinib in Colorectal Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Colorectal Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02119676).
- Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02117479).